e-learning
resources
Virtual 2020
Monday, 07.09.2020
Is the global warming potential of inhaler propellants significant?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Con
O. Usmani (London, United Kingdom)
Source:
Virtual Congress 2020 – Is the global warming potential of inhaler propellants significant?
Session:
Is the global warming potential of inhaler propellants significant?
Session type:
Pro/Con debate
Number:
4140
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Usmani (London, United Kingdom). Con. Virtual Congress 2020 – Is the global warming potential of inhaler propellants significant?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Mobile video directly observed therapy can be used to improve at-home inhaler technique in children with asthma
New inhaler devices: the good, the bad, and the ugly
Clinically appropriate testing of different valved holding chamber (VHC)-facemask combinations investigating simulated delivered mass to carina
Related content which might interest you:
Is PD1/PD-L1 Resting ready for clinical practice? Con
Source: International Congress 2016 – Do we really need PD1/PD-L1 status and next generation sequencing to treat lung cancer?
Year: 2016
High-intensity NIV in COPD: the Con position
Source: Annual Congress 2013 –Long-term home ventilation: towards the optimal target!
Year: 2013
Can animal models really teach us anything about pneumonia? Con
Source: Eur Respir J, 55 (1) 1901525; 10.1183/13993003.01525-2019
Year: 2020
Lipopolysaccharide (LPS) inhalation causes an increase in activated neutrophils and lymphocytes
Source: Eur Respir J 2001; 18: Suppl. 33, 108s
Year: 2001
Lipopolysaccharide (LPS) inhalation causes an increase in mucosal CD8+ve cells
Source: Eur Respir J 2001; 18: Suppl. 33, 316s
Year: 2001
The eosinophil is important in asthma after all – Con
Source: Annual Congress 2006 - Pro/Con: asthma is (not) an inflammatory disease
Year: 2006
Con: continuous positive airway pressure and cardiovascular prevention
Source: Eur Respir J, 51 (5) 1702721; 10.1183/13993003.02721-2017
Year: 2018
Should steroids be used in community-acquired pneumonia? Con argument
Source: International Congress 2017 – Controversies in community-acquired pneumonia: a pro and con debate
Year: 2017
Con: should asymptomatic patients with moderate-to-severe ?OSA be treated?
Source: Breathe, 15 (1) 11; 10.1183/20734735.0347-2018
Year: 2019
Screening mimic peptide of lipopolysaccharide binding protein binding to CD14
Source: Annual Congress 2007 - Lung injury and repair: from
in vitro
to
in vivo
Year: 2007
Differential properties of mucosubstance produced by allergic inflammation and lipopolysaccharide (LPS) stimulation in rat nasal epithelium
Source: Eur Respir J 2002; 20: Suppl. 38, 482s
Year: 2002
Dose serum mannose binding lectin (MBL) influence allergic disorders?
Source: Eur Respir J 2004; 24: Suppl. 48, 395s
Year: 2004
Poly I:C treatment causes fatal AHR in sensitized mice
Source: Annual Congress 2011 - Animal models of airway inflammation
Year: 2011
NIV in all postoperative patients after extensive surgery - Con
Source: Annual Congress 2007 - Noninvasive positive pressure ventilation (NIV) in acute respiratory failure (ARF) - pro and con debate
Year: 2007
IFN γ and IL2 secretion in whole blood culture after simulation with mitogens in patients with tuberculosis- comparison with healthy donors
Source: Eur Respir J 2001; 18: Suppl. 33, 108s
Year: 2001
Should severe CAP patients receive anti-MRSA coverage? Con argument
Source: International Congress 2017 – Controversies in community-acquired pneumonia: a pro and con debate
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept